Another promising candidate is SAMD5, whose SAM domain is similar to SHIP2 SAM (Figure 4A) and highly expressed in breast cancer cells and mainly cytoplasmic (Lo et al., 2015). This evidence concerns the gene SAMD5 and breast carcinoma.